Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) leading to improved adverse effects for example drowsiness, although the clinical relevance is reduced in most patients – monitor the affected individual for adverse effects (e.If individual can't resume their regular oral medication